Tumor evolution metrics predict recurrence beyond 10 years in locally advanced prostate cancer.

Fernandez-Mateos J, Cresswell GD, Trahearn N, Webb K, Sakr C, Lampis A, Stuttle C, Corbishley CM, Stavrinides V, Zapata L, Spiteri I, Heide T, Gallagher L, James C, Ramazzotti D, Gao A, Kote-Jarai Z, Acar A, Truelove L, Proszek P, Murray J, Reid A, Wilkins A, Hubank M, Eeles R, Dearnaley D, Sottoriva A

Open source

DOI: 10.1038/s43018-024-00787-0
Published: 2024 Sep
Container: Nature cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s43018-024-00787-0,
  title = {Tumor evolution metrics predict recurrence beyond 10 years in locally advanced prostate cancer.},
  author = {Fernandez-Mateos J and Cresswell GD and Trahearn N and Webb K and Sakr C and Lampis A and Stuttle C and Corbishley CM and Stavrinides V and Zapata L and Spiteri I and Heide T and Gallagher L and James C and Ramazzotti D and Gao A and Kote-Jarai Z and Acar A and Truelove L and Proszek P and Murray J and Reid A and Wilkins A and Hubank M and Eeles R and Dearnaley D and Sottoriva A},
  year = {2024},
  journal = {Nature cancer},
  doi = {10.1038/s43018-024-00787-0},
  url = {https://doi.org/10.1038/s43018-024-00787-0}
}

RIS

TY  - JOUR
TI  - Tumor evolution metrics predict recurrence beyond 10 years in locally advanced prostate cancer.
AU  - Fernandez-Mateos J
AU  - Cresswell GD
AU  - Trahearn N
AU  - Webb K
AU  - Sakr C
AU  - Lampis A
AU  - Stuttle C
AU  - Corbishley CM
AU  - Stavrinides V
AU  - Zapata L
AU  - Spiteri I
AU  - Heide T
AU  - Gallagher L
AU  - James C
AU  - Ramazzotti D
AU  - Gao A
AU  - Kote-Jarai Z
AU  - Acar A
AU  - Truelove L
AU  - Proszek P
AU  - Murray J
AU  - Reid A
AU  - Wilkins A
AU  - Hubank M
AU  - Eeles R
AU  - Dearnaley D
AU  - Sottoriva A
PY  - 2024
JO  - Nature cancer
DO  - 10.1038/s43018-024-00787-0
UR  - https://doi.org/10.1038/s43018-024-00787-0
ER  -

APA

J, F., GD, C., N, T., K, W., C, S., A, L., C, S., CM, C., V, S., L, Z., I, S., T, H., L, G., C, J., D, R., A, G., Z, K., A, A., L, T., P, P., J, M., A, R., A, W., M, H., R, E., D, D., & A, S. (2024). Tumor evolution metrics predict recurrence beyond 10 years in locally advanced prostate cancer.. Nature cancer. https://doi.org/10.1038/s43018-024-00787-0

Source records

pubmed · retrieved 2026-09-26T03:24:20.377Z